Men's Wearhouse: Why It's Time To Take Profits Ahead of Earnings

NEW YORK (TheStreet) -- It would be a gross understatement to say once-struggling apparel retailer Men's Wearhouse (MW) has seemingly turned around its fortunes and that of its shareholders, posting 2015 stock gains of 34%.

And not only are Men's Wearhouse shares crushing the broader averages this year, but the Houston-based suit specialist, which picked off rival Jos. A. Bank last year, is also dominating the 3% gains in the SPDR S&P Retail ETF (XRT), home to prominent retailers such as Costco (COST) and Home Depot (HD).

But how much more runway can there be in Men's Wearhouse stock? That is the question that investors must ask ahead of the company's first-quarter earnings results due out Wednesday after the close.

For the fiscal first quarter that ended in April, the average earnings estimate calls for earnings of 51 cents a share, down 26% from a year earlier, while revenue is projected to be 36% higher to $857 million. For the full year ending in January, the average earnings estimate of $2.87 a share would be an 11% year-over-year climb, while projected full-year revenue of $3.67 billion would be up 13%.

The prudent play here would be to take some profits off the table now and wait to hear what the company has to say about expectations for the next quarter and the full year.

Why? It has been feast or famine so far in the retail sector.

Even traditional powers such as Lowe's (LOW) have fallen prey to weak consumer spending.

But in the case of Men's Wearhouse, what is also important to consider is that the company isn't that far removed from its struggles, missing analysts' average revenue estimates three times in the past six quarters and twice in the past three. During that span, it has missed earnings two times.

And prior to the stock's 34% surge this year, Men's Wearhouse shares had plummeted some 31%, falling from a July high of about $49 to a low of $40.49.

If you liked this article you might like

What To Sell: 3 Sell-Rated Dividend Stocks PAGP, NRZ, MW

What To Sell: 3 Sell-Rated Dividend Stocks MOS, PAGP, MW

What To Sell: 3 Sell-Rated Dividend Stocks MW, OUT, OXY

Walgreens' Antitrust Rx Is Addition by Subtraction

Men's Wearhouse-Jos. A. Bank Battle Leaves Lasting Scars